(Total Views: 93)
Posted On: 09/08/2023 10:25:48 AM
Post# of 21236

$CTXR News Article - Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR(TM) https://marketwirenews.com/news-releases/citi...16795.html


My Twitter: WhyteStocks